Literature DB >> 2476816

Differences in the negative allosteric modulation of gamma-aminobutyric acid receptors elicited by 4'-chlorodiazepam and by a beta-carboline-3-carboxylate ester: a study with natural and reconstituted receptors.

G Puia1, M R Santi, S Vicini, D B Pritchett, P H Seeburg, E Costa.   

Abstract

Cl- currents elicited by gamma-aminobutyric acid (GABA) application were recorded with the whole-cell tight-seal technique from voltage-clamped cortical neurons of neonatal rats in primary culture. The peripheral benzodiazepine recognition site ligand 4'-chlorodiazepam [Ro 5-4864; 7-chloro-1,3-dihydro-1-methyl-5-(4-chlorophenyl)-2H-[1,4]-benzodiazep in-2- one] inhibited the GABA-generated currents in a dose-dependent manner. Also, a beta-carboline (DMCM; 6,7-dimethoxy-4-ethyl-beta-carboline-3-carboxylate methyl ester), acting as a negative allosteric modulator of GABAA receptors, reduced the intensity of GABA-generated currents with similar efficacy but greater potency. Flumazenil (Ro 15-1788; 8-fluro-5,6-dihydro-5-methyl-6-oxo-4H-imidazo-[1,5-a] [1,4]-benzodiazepine-3-carboxylate ethyl ester) antagonized DMCM inhibition but not that elicited by 4'-chlorodiazepam. The isoquinoline carboxamide PK 11195, an antagonist of 4'-chlorodiazepam effects in other systems, failed to antagonize the action of 4'-chlorodiazepam. The transient expression of various molecular forms of GABAA receptors in the human embryonic kidney cell line 293 allowed a study of the minimal structural requirements for the inhibition of GABA-induced Cl- currents by bicuculline, picrotoxin, 4'-chlorodiazepam, and DMCM. GABA-elicited Cl- currents in cells coexpressing alpha 1 and beta 1 subunits of GABAA receptors were inhibited by bicuculline and picrotoxin, but not by DMCM or 4'-chlorodiazepam. Conversely, the GABA currents in cells coexpressing alpha 1 beta 1 and gamma 2 subunits were inhibited by bicuculline, picrotoxin, 4'-chlorodiazepam, and DMCM. Since the Cl- currents generated by GABA in some molecular forms of GABAA receptors are inhibited by bicuculline and picrotoxin only, 4'-chlorodiazepam cannot be acting isosterically with picrotoxin.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2476816      PMCID: PMC298040          DOI: 10.1073/pnas.86.18.7275

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  22 in total

1.  Benzodiazepine receptors in rat brain.

Authors:  R F Squires; C Brastrup
Journal:  Nature       Date:  1977-04-21       Impact factor: 49.962

2.  Sequence and expression of human GABAA receptor alpha 1 and beta 1 subunits.

Authors:  P R Schofield; D B Pritchett; H Sontheimer; H Kettenmann; P H Seeburg
Journal:  FEBS Lett       Date:  1989-02-27       Impact factor: 4.124

3.  Specific high-affinity binding sites for [3H]Ro 5-4864 in rat brain and kidney.

Authors:  H Schoemaker; R G Boles; W D Horst; H I Yamamura
Journal:  J Pharmacol Exp Ther       Date:  1983-04       Impact factor: 4.030

4.  Improved patch-clamp techniques for high-resolution current recording from cells and cell-free membrane patches.

Authors:  O P Hamill; A Marty; E Neher; B Sakmann; F J Sigworth
Journal:  Pflugers Arch       Date:  1981-08       Impact factor: 3.657

5.  Characterization of peripheral-type benzodiazepine binding sites in brain using [3H]Ro 5-4864.

Authors:  P J Marangos; J Patel; J P Boulenger; R Clark-Rosenberg
Journal:  Mol Pharmacol       Date:  1982-07       Impact factor: 4.436

6.  Transient expression shows ligand gating and allosteric potentiation of GABAA receptor subunits.

Authors:  D B Pritchett; H Sontheimer; C M Gorman; H Kettenmann; P H Seeburg; P R Schofield
Journal:  Science       Date:  1988-12-02       Impact factor: 47.728

7.  RO5-4864 inhibits the binding of [35S]t-butylbicyclophosphorothionate to rat brain membranes.

Authors:  M K Ticku; R Ramanjaneyulu
Journal:  Life Sci       Date:  1984-02-13       Impact factor: 5.037

8.  Electrophysiological and pharmacological actions of the convulsant benzodiazepine Ro 5-4864.

Authors:  B A Weissman; J Cott; D Hommer; S Paul; P Skolnick
Journal:  Eur J Pharmacol       Date:  1984-01-27       Impact factor: 4.432

9.  Characterization of photoaffinity labeling of benzodiazepine binding sites.

Authors:  J W Thomas; J F Tallman
Journal:  J Biol Chem       Date:  1981-10-10       Impact factor: 5.157

10.  Selective antagonists of benzodiazepines.

Authors:  W Hunkeler; H Möhler; L Pieri; P Polc; E P Bonetti; R Cumin; R Schaffner; W Haefely
Journal:  Nature       Date:  1981-04-09       Impact factor: 49.962

View more
  9 in total

1.  DBI mRNA is expressed in endocrine pancreas and its post-translational product DBI(33-50) inhibits insulin release.

Authors:  P Borboni; R Magnaterra; O Porzio; A Fusco; G Sesti; A Bertoli; R Lauro; L N Marlier
Journal:  Endocrine       Date:  1995-04       Impact factor: 3.633

Review 2.  Pharmacological and molecular basis for dopamine D-2 receptor diversity.

Authors:  M Memo
Journal:  Mol Neurobiol       Date:  1990 Fall-Winter       Impact factor: 5.590

3.  Clozapine and some other antipsychotic drugs may preferentially block the same subset of GABA(A) receptors.

Authors:  R F Squires; E Saederup
Journal:  Neurochem Res       Date:  1997-02       Impact factor: 3.996

Review 4.  The diversity of GABAA receptors. Pharmacological and electrophysiological properties of GABAA channel subtypes.

Authors:  W Hevers; H Lüddens
Journal:  Mol Neurobiol       Date:  1998-08       Impact factor: 5.590

5.  gamma-Aminobutyric acid type A receptor point mutation increases the affinity of compounds for the benzodiazepine site.

Authors:  D B Pritchett; P H Seeburg
Journal:  Proc Natl Acad Sci U S A       Date:  1991-02-15       Impact factor: 11.205

6.  Expression patterns of gamma-aminobutyric acid type A receptor subunit mRNAs in primary cultures of granule neurons and astrocytes from neonatal rat cerebella.

Authors:  P Bovolin; M R Santi; G Puia; E Costa; D Grayson
Journal:  Proc Natl Acad Sci U S A       Date:  1992-10-01       Impact factor: 11.205

7.  The benzodiazepine receptor antagonists flumazenil and CGS8216 block the enhancement of fear conditioning and interference with escape behavior produced by inescapable shock.

Authors:  S F Maier; R E Grahn; S Maswood; L R Watkins
Journal:  Psychopharmacology (Berl)       Date:  1995-09       Impact factor: 4.530

8.  The anti-epileptic drug levetiracetam reverses the inhibition by negative allosteric modulators of neuronal GABA- and glycine-gated currents.

Authors:  J-M Rigo; G Hans; L Nguyen; V Rocher; S Belachew; B Malgrange; P Leprince; G Moonen; I Selak; A Matagne; H Klitgaard
Journal:  Br J Pharmacol       Date:  2002-07       Impact factor: 8.739

9.  Pharmacological intervention to restore connectivity deficits of neuronal networks derived from ASD patient iPSC with a TSC2 mutation.

Authors:  Mouhamed Alsaqati; Vivi M Heine; Adrian J Harwood
Journal:  Mol Autism       Date:  2020-10-19       Impact factor: 7.509

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.